Neopharm Life Sciences

September 19, 2024

Neopharm Life Sciences, offers a comprehensive suite of RNA analysis services tailored to meet the changing needs of the biotechnology and life sciences industries. Services are designed to support researchers, pharmaceutical and biotech companies at every stage of the product development lifecycle, from early discovery to commercial launch and beyond.

– RNA analysis services
– Identity confirmation
– Impurity detection
– Specialized ASO RNA analysis

Industry news

Panagiotis Prinos appointed as Director of Réseau DePTAQ

December 19, 2024

AReNA attended FISQ

December 19, 2024

AReNA attends CASTL’s Open Door Day

November 15, 2024

Epitopea closes their $31 million pre-Series A financing.

October 21, 2024

Congratulations to the Nobel Prize winners in Medicine!

September 19, 2024

Congratulations to the 23 recipients of the D2R funding programs

The creation of training programs to meet the needs of the RNA therapeutics industry

The creation of a biomanufacturing services platform to boost expertise in Quebec and accelerate the development of RNA therapies

A new initiative to stimulate innovation and entrepreneurship in the RNA therapy sector in Quebec

Quebec Launches AReNA to Become a Global Leader in RNA Therapies

A group of partners are launching the CELLULE to accelerate the development of RNA therapies in Quebec

The long-overlooked molecule that will define a generation of science